Introduction: In 2020, Oregon became the first US state to legalize state-regulated psilocybin services. This study aims to examine: 1) the clinical and demographic characteristics, 2) psilocybin use motivations, and 3) differences in preparedness among patients seeking care in a Oregon- based pilot consult service specializing in psilocybin risk reduction. Methods: This retrospective chart...
AbstractAny attempt at consciousness assessment in organoids requires careful consideration of the theory of consciousness that researchers will rely on when performing this task. In cognitive neuroscience and the clinic, there are tools and theories used to detect and measure consciousness, typically in human beings, but none of them is neither fully consensual nor fit for the biological...
10.1080/21507740.2022.2048726. Stoekl e, H. C., A. Ivasilevitch, G. Marignac, and C. Herv e. 2021. Creation and use of organoids in biomedical research and healthcare: The bioethical and metabioethical issues. Cell Adhesion & Migration 15 (1):285–94. doi: 10.1080/19336918.2021.1996749. Stoekl e, H. C., L. Ladrat, T. Landrin, P. Beuzeboc, and C. Herv e. 2022. Bio-ethical issues in oncology...
Human cerebral organoids (HCOs) are model systems that enable researchers to investigate the human brain in ways that had previously been impossible. The emergence of HCOs was accompanied by both expert and layperson discussions concerning the possibility of these novel entities developing sentience or consciousness. Such concerns are reflected in deliberations about how to handle and regulate...